Biotech
MANCHESTER, NH: Trial to Include Chinese Subjects With Pre-Diabetes ...
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 10/05/15 -- Flamel Technologies (NASDAQ: FLML) announced today that the Company's Irish subsidiary, Flamel Ireland Limited, has licensed exclusive U.S. rights to ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 10/05/15 -- Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE: HEM), a clinical-stage autologous cell-therapy company, announced to ...
DUBLIN, IRELAND: Positive Study Results Support Company's Current Development and Regulatory Efforts for VIBATIV ...
DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 10/02/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today that stock options to purchase ...
MINNEAPOLIS, MN: Healthcare Executive Brings Extensive Public Company Financial Experience to Leadership Team ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 10/01/15 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the third quarter ended August 31, 2015.Third quarter ...
LAVAL, QUEBEC: - ProMetic allowed to proceed with filing of IND for pivotal study ahead of anticipated timelines - PBI-4050 to be added in combination to commercially available drugs in pivotal study ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/30/15 -- SciVac Therapeutics Inc. ("SciVac" or the "Company") (TSX: VAC)(OTCQX: SVACF) today announced the results for its Annu ...
NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 09/30/15 -- iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced a notice of allow ...
MINNEAPOLIS, MN: Two Experienced Healthcare Executives Join Board as Company Prepares to Enroll First Patient in Phase 1 Clinical Trial ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 09/30/15 -- Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE: RVV) today announced interim results from the ongoing Phase 2a ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 09/30/15 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TR), an immuno-oncology company developing innovative therapies for the treatment of cancer, today ann ...
SAN FRANCISCO, CA: Medivation Announces Appointment of Mohammad Hirmand, M.D., as Interim CMO; Lynn Seely, M.D., Retiring From CMO Position; New Hires Complement Current Leadership Expertise ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/28/15 -- M Pharmaceutical, Inc. (CSE: MQ)(OTCQB: MPHMF)(FRANKFURT: T3F2), (the "Company"), a clinical-stage company developing innovative ...
MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 09/28/15 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the ...
